Cas:649773-74-0 3-[[2-(4-chloro-3-methylphenoxy)acetyl]amino]benzoic acid manufacturer & supplier

We serve Chemical Name:3-[[2-(4-chloro-3-methylphenoxy)acetyl]amino]benzoic acid CAS:649773-74-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-[[2-(4-chloro-3-methylphenoxy)acetyl]amino]benzoic acid

Chemical Name:3-[[2-(4-chloro-3-methylphenoxy)acetyl]amino]benzoic acid
CAS.NO:649773-74-0
Synonyms:Benzoic acid,3-[[(4-chloro-3-methylphenoxy)acetyl]amino]
Molecular Formula:C16H14ClNO4
Molecular Weight:319.74000
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:79.12000
Exact Mass:319.06100
LogP:4.01360

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Benzoic acid,3-[[(4-chloro-3-methylphenoxy)acetyl]amino] chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzoic acid,3-[[(4-chloro-3-methylphenoxy)acetyl]amino] physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzoic acid,3-[[(4-chloro-3-methylphenoxy)acetyl]amino] Use and application,Benzoic acid,3-[[(4-chloro-3-methylphenoxy)acetyl]amino] technical grade,usp/ep/jp grade.


Related News: Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities. 3-[[2-(4-chloro-3-methylphenoxy)acetyl]amino]benzoic acid manufacturer The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. 3-[[2-(4-chloro-3-methylphenoxy)acetyl]amino]benzoic acid supplier Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday. 3-[[2-(4-chloro-3-methylphenoxy)acetyl]amino]benzoic acid vendor The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. 3-[[2-(4-chloro-3-methylphenoxy)acetyl]amino]benzoic acid factory According to statistics from the Price Supervision and Competition Bureau of the National Development and Reform Commission, China can produce more than 1,500 kinds of bulk drugs, with a total output of one million tons and an export volume of more than 60%. It has become the world’s second largest drug substance after the United States. Country of manufacture and largest exporter.